- Filed
- Nov 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Nov 14, 2024 | 291.56M sh |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $6.3M |
| Cash And Equivalents | Q2 2025 · Mar 31, 2024 | $5.16M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $2.63M |
| Current Liabilities | Q2 2025 · Mar 31, 2024 | $2.27M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $2.68M |
| Total Liabilities | Q2 2025 · Mar 31, 2024 | $2.36M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $6.8M |
| Current Assets | Q2 2025 · Mar 31, 2024 | $5.45M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $7.05M |
| Total Assets | Q2 2025 · Mar 31, 2024 | $5.78M |
| Sga Expense | Q2 2025 · Sep 30, 2024 | $273.76K |
| Sga Expense | Q2 2025 · Sep 30, 2024 | $522.54K |
| Sga Expense | Q2 2025 · Sep 30, 2023 | $123.92K |
| Sga Expense | Q2 2025 · Sep 30, 2023 | $278.57K |
| Capex | Q2 2025 · Sep 30, 2023 | $92.69K |
| Operating Cash Flow | Q2 2025 · Sep 30, 2023 | $2.72M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $3.02M |
| Stockholders Equity | Q2 2025 · Jun 30, 2023 | $2.75M |
| Stockholders Equity | Q2 2025 · Mar 31, 2023 | $1.81M |
| Eps Diluted restated | Q2 2025 · Sep 30, 2023 | $0.00 |
| Eps Diluted restated | Q2 2025 · Sep 30, 2023 | $0.00 |
| Eps Basic restated | Q2 2025 · Sep 30, 2023 | $0.00 |
| Eps Basic restated | Q2 2025 · Sep 30, 2023 | $0.00 |
| Net Income | Q2 2025 · Sep 30, 2023 | $268.61K |
| Net Income | Q2 2025 · Sep 30, 2023 | $1.21M |
| Operating Income | Q2 2025 · Sep 30, 2023 | $326.17K |
| Operating Income | Q2 2025 · Sep 30, 2023 | $1.4M |
| Gross Profit | Q2 2025 · Sep 30, 2023 | $450.09K |
| Gross Profit | Q2 2025 · Sep 30, 2023 | $1.68M |
| Revenue | Q2 2025 · Sep 30, 2023 | $1.16M |
| Revenue | Q2 2025 · Sep 30, 2023 | $4.44M |